Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  mucositis
Trial Type:  Supportive care
Results 1-16 of 16 for your search:
Start Over
Doxepin Hydrochloride or DLA Rinse in Reducing Oral Mucositis Pain in Patients with Head and Neck Cancer undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221304, NCI-2014-01877, NCT02229539
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 603EUSA03, NCI-2010-01741, NCT00901732
Topical Phenylephrine Solution in Preventing Oral Mucositis in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: UW14068, NCI-2015-00576, 2015-0062, 2015-0062-CP003, NCT02434146
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: IOM-HNC-201-IL, NCI-2015-01924, NCT01400620
Ketamine Hydrochloride in Reducing Pain in Patients With Mucositis Undergoing Chemoradiation or Radiation Therapy For Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: DMS 1022, NCI-2012-01913, D1022, NCT01653327
Personalized Humidification Device in Improving Quality of Life and Reducing Side Effects in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 13-10937, NCI-2013-01745, 072084, 13202, NCT01930435
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase: Phase II
Type: Supportive care
Age: 55 and over
Trial IDs: CLT008-03, NCI-2014-02461, NCT02282215
Phase 2 Study to Evaluate the Safety & Efficacy of Brilacidin Oral Rinse in Patients With Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: CTIX-BRI-205, NCI-2015-01491, NCT02324335
A Mouth Rinse Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: SAN005-01, NCI-2015-02029, NCT02399228
Individualized High Dose Methotrexate in Treating Younger Patients With Cancer and Significant Risk for Side Effects
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 1 to 22
Trial IDs: H-33119, NCI-2014-00923, NCT02076997
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients with Head and Neck Cancer Undergoing Radiation Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: MC13C2, NCI-2014-00865, Mod13-007632-07, NCT02123511
Pregabalin in Reducing Mucositis Pain in Patients with Oropharyngeal Cancer Undergoing Chemoradiation Therapy
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 819255, NCI-2014-02239, 43313, 819266, UPCC 43313, NCT02277548
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients with Stage II-IV Head and Neck Cancer during Chemoradiation
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: I 262314, NCI-2015-01338, NCT02531906
Start Over